139 related articles for article (PubMed ID: 7515632)
1. Treatment of patients with metastatic melanoma with a one day regimen of dacarbazine, vincristine, bleomycin and lomustine plus interferon-alpha.
Vuoristo M; Gröhn P; Kumpulainen E; Korpela M
Eur J Cancer; 1994; 30A(3):420. PubMed ID: 7515632
[No Abstract] [Full Text] [Related]
2. Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma.
Vuoristo MS; Hahka-Kemppinen M; Parvinen LM; Pyrhönen S; Seppä H; Korpela M; Kellokumpu-Lehtinen P
Melanoma Res; 2005 Aug; 15(4):291-6. PubMed ID: 16034308
[TBL] [Abstract][Full Text] [Related]
3. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.
Punt CJ; van Herpen CM; Jansen RL; Vreugdenhil G; Muller EW; de Mulder PH
Br J Cancer; 1997; 76(2):266-9. PubMed ID: 9231931
[TBL] [Abstract][Full Text] [Related]
4. Systemic chemotherapy in the treatment of malignant melanoma.
Lens MB; Eisen TG
Expert Opin Pharmacother; 2003 Dec; 4(12):2205-11. PubMed ID: 14640919
[TBL] [Abstract][Full Text] [Related]
5. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma.
Pyrhönen S; Hahka-Kemppinen M; Muhonen T; Nikkanen V; Eskelin S; Summanen P; Tarkkanen A; Kivelä T
Cancer; 2002 Dec; 95(11):2366-72. PubMed ID: 12436444
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of malignant melanoma].
Jedrzejczak WW
Pol Arch Med Wewn; 1998 Oct; 100(4):294-9. PubMed ID: 10335037
[No Abstract] [Full Text] [Related]
7. Bacterial Sepsis Increases Survival in Metastatic Melanoma: Chlamydophila Pneumoniae Induces Macrophage Polarization and Tumor Regression.
Buzás K; Marton A; Vizler C; Gyukity-Sebestyén E; Harmati M; Nagy K; Zvara Á; Katona RL; Tubak V; Endrész V; Németh IB; Oláh J; Vígh L; Bíró T; Kemény L
J Invest Dermatol; 2016 Apr; 136(4):862-865. PubMed ID: 26743601
[No Abstract] [Full Text] [Related]
8. Long-term Survival of Stage IV Melanoma Patients Treated with BOLD Combination Chemotherapy and Intermediate-dose Subcutaneous Interferon-alpha.
Mattila K; Raanta P; Lahtela V; Pyrhönen S; Koskivuo I; Vihinen P
Anticancer Res; 2018 Nov; 38(11):6393-6397. PubMed ID: 30396963
[TBL] [Abstract][Full Text] [Related]
9. Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma.
Kivelä T; Suciu S; Hansson J; Kruit WH; Vuoristo MS; Kloke O; Gore M; Hahka-Kemppinen M; Parvinen LM; Kumpulainen E; Humblet Y; Pyrhönen S
Eur J Cancer; 2003 May; 39(8):1115-20. PubMed ID: 12736111
[TBL] [Abstract][Full Text] [Related]
10. Use of combination chemotherapy with CCNU, bleomycin, and vincristine in the treatment of metastatic melanoma in patients resistant to DTIC therapy.
Everall JD; Dowd PM
Cancer Treat Rep; 1979 Jan; 63(1):151-5. PubMed ID: 84710
[No Abstract] [Full Text] [Related]
11. Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF.
Bottoni U; Bonaccorsi P; Devirgiliis V; Panasiti V; Borroni RG; Trasimeni G; Clerico R; Calvieri S
Jpn J Clin Oncol; 2005 Sep; 35(9):507-13. PubMed ID: 16120623
[TBL] [Abstract][Full Text] [Related]
12. Dacarbazine, vincristine, bleomycin and lomustine plus natural interferon-alpha for metastatic melanoma.
Reinhold U; Bruske T; Kreysel HW
Eur J Cancer; 1996 Jan; 32A(1):180. PubMed ID: 8695233
[No Abstract] [Full Text] [Related]
13. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma.
Pyrhönen S; Hahka-Kemppinen M; Muhonen T
J Clin Oncol; 1992 Dec; 10(12):1919-26. PubMed ID: 1280673
[TBL] [Abstract][Full Text] [Related]
14. BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy.
Nathan FE; Berd D; Sato T; Shield JA; Shields CL; De Potter P; Mastrangelo MJ
J Exp Clin Cancer Res; 1997 Jun; 16(2):201-8. PubMed ID: 9261748
[TBL] [Abstract][Full Text] [Related]
15. Intermittent interferon and polychemotherapy in metastatic melanoma.
Vuoristo MS; Gröhn P; Kellokumpu-Lehtinen P; Kumpulainen E; Turunen M; Korpela M; Joensuu H; Tiusanen K; Nevantaus A
J Cancer Res Clin Oncol; 1995; 121(3):175-80. PubMed ID: 7536196
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma.
De Wasch G; Bernheim J; Michel J; Lejeune F; Kenis Y
Cancer Treat Rep; 1976 Sep; 60(9):1273-6. PubMed ID: 65222
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin, vincristine, lomustine, and DTIC chemotherapy for metastatic melanoma.
York RM; Foltz AT
Cancer; 1988 Jun; 61(11):2183-6. PubMed ID: 2452681
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit.
Lakhani S; Selby P; Bliss JM; Perren TJ; Gore ME; McElwain TJ
Br J Cancer; 1990 Feb; 61(2):330-4. PubMed ID: 1690022
[TBL] [Abstract][Full Text] [Related]
19. Single drug and combination chemotherapy in the treatment. Disseminated malignant melanoma.
Aranha GV; Grage TB
Minn Med; 1977 Aug; 60(8):543-8. PubMed ID: 882082
[No Abstract] [Full Text] [Related]
20. Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.
Cohen SM; Ohnuma T; Ambinder EP; Holland JF
Cancer Treat Rep; 1986 May; 70(5):688-9. PubMed ID: 2423239
[No Abstract] [Full Text] [Related]
[Next] [New Search]
